epigallocatechin gallate has been researched along with Experimental Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Guo, Y; Xu, J; Zhao, Y | 1 |
| Chen, L; Guo, X; Hu, Y; Li, L; Liang, G; Zhang, G | 1 |
| Chen, H; Fang, MZ; Huang, SL; Jin, HY; Kong, DS; Li, M; Sun, Y; Wang, SM; Wang, XF; Wang, Y; Zhang, X | 1 |
| Le, CT; Leenders, WPJ; Molenaar, RJ; van Noorden, CJF | 1 |
| Jiang, A; Liu, L; Liu, Y; Ma, L; Mao, F; Zhai, X; Zhou, J | 1 |
| Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Ramakrishna, S; Ravuri, HG | 1 |
| Chu, PY; Ko, HY; Lin, YH; Tsai, SC; Wu, CC | 1 |
| Fujiki, H; Sueoka, E; Suganuma, M | 1 |
| Jankun, J; Keck, RW; Selman, SH | 1 |
| Ahn, WS; Bae, DH; Mun, ST | 1 |
| Chang, X; Chen, Y; Cheng, S; Dinlin, X; Fang, S; Gu, X; Hou, X; Hu, Q; Mo, Y; Rong, C; Wang, Q; Yan, R; Yang, C; Yao, H; Zhao, L | 1 |
| Choo, EJ; Jeong, MS; Jung, DB; Jung, JH; Kaihatsu, K; Kato, N; Kim, B; Kim, EO; Kim, SH; Lee, H; Srivastava, SK; Yun, M | 1 |
| Chen, ZR; Feng, CL; Hsieh, CH; Lai, CH; Lin, YH | 1 |
| Adhami, VM; Ahmad, N; Asim, M; Bharali, DJ; Cui, H; Hafeez, BB; Khwaja, SI; Mousa, SA; Mukhtar, H; Siddiqui, IA | 1 |
| Cha, HY; Chaudhary, SC; Kim, M; Kwak, IH; Lee, BS; Lee, JH; Nam, HJ; Pai, KS; Shin, YH | 1 |
| Chen, CC; Hsieh, DS; Lu, HC; Wu, CJ; Yeh, MK | 1 |
| Asosingh, K; Menu, E; Van Camp, B; Van Riet, I; Van Valckenborgh, E; Vande Broek, I; Vanderkerken, K | 1 |
| Liu, J; Wei, D; Zhang, Q | 1 |
| Fang, JY; Huang, YL; Hung, CF; Hwang, TL | 1 |
| Sharma, M; Sharma, PD; Singh, TV; Vyas, S | 1 |
| Conney, AH; Huang, M; Lou, Y; Lu, Y; Xie, J | 1 |
| Surh, Y | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
5 review(s) available for epigallocatechin gallate and Experimental Neoplasms
| Article | Year |
|---|---|
Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Cell Proliferation; Central Nervous System Neoplasms; Combined Modality Therapy; Endoplasmic Reticulum Chaperone BiP; Epidemiologic Studies; Glioma; Humans; Neoplasms, Experimental; Signal Transduction; Tea | 2018 |
Tumor promoters: from chemicals to inflammatory proteins.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Gastrointestinal Neoplasms; Helicobacter Infections; Humans; Inflammation; Inflammation Mediators; Neoplasms, Experimental; Okadaic Acid; Organ Specificity; Skin Neoplasms | 2013 |
Inhibitory effect of green and black tea on tumor growth.
Topics: Animals; Apoptosis; Catechin; DNA Replication; DNA, Neoplasm; Mice; Neoplasms, Experimental; Phytotherapy; Plant Extracts; Tea | 1999 |
Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Topics: Animals; Capsaicin; Catechin; Catechols; Curcumin; Diet; Fatty Alcohols; Humans; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plants, Edible; Plants, Medicinal; Resveratrol; Stilbenes | 1999 |
A new function of green tea: prevention of lifestyle-related diseases.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Catechin; Cohort Studies; Cricetinae; Female; Gene Expression Regulation; Humans; Interleukin-6; Japan; Life Style; Lung; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; NF-kappa B; Okadaic Acid; Phytotherapy; Primary Prevention; Prospective Studies; Pulmonary Fibrosis; Rats; Risk; Tea; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2001 |
19 other study(ies) available for epigallocatechin gallate and Experimental Neoplasms
| Article | Year |
|---|---|
Design and construction of IR780- and EGCG-based and mitochondrial targeting nanoparticles and their application in tumor chemo-phototherapy.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Indoles; Iodides; Materials Testing; Mitochondria; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Photosensitizing Agents; Photothermal Therapy; Zebrafish | 2021 |
Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Catechin; Cell Proliferation; Chick Embryo; Chickens; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Injections, Intraperitoneal; KB Cells; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Experimental; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vincristine | 2020 |
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Carcinogenesis; Catechin; Cell Proliferation; Colon; Colorectal Neoplasms; Dimethylhydrazines; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Intestinal Mucosa; Male; Neoplasms, Experimental; Protein Interaction Maps; Rats; Rectum; Signal Transduction | 2020 |
Biocompatible Heat-Shock Protein Inhibitor-Delivered Flowerlike Short-Wave Infrared Nanoprobe for Mild Temperature-Driven Highly Efficient Tumor Ablation.
Topics: Animals; Catechin; Cell Line, Tumor; Coated Materials, Biocompatible; HSP90 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Infrared Rays; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanostructures; Neoplasm Proteins; Neoplasms, Experimental | 2019 |
Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Biological Transport; Bombesin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Liberation; Female; Humans; Lecithins; Liposomes; Mice, Inbred C57BL; Nanocapsules; Neoplasms, Experimental; Stearic Acids; Surface Properties | 2019 |
Co-Delivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
Topics: Animals; Catechin; Curcumin; Drug Delivery Systems; Humans; Hyaluronan Receptors; Male; Mice; Mice, SCID; Neoplasm Proteins; Neoplasms, Experimental; P-Selectin; PC-3 Cells; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model.
Topics: Animals; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Mitomycin; Neoplasms, Experimental; Rats; Urinary Bladder Neoplasms | 2014 |
Epigallocatechin gallate with photodynamic therapy enhances anti-tumor effects in vivo and in vitro.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Combinations; Drug Synergism; Female; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Treatment Outcome; Tumor Burden | 2014 |
(-)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein.
Topics: Acetylation; Amyloid beta-Protein Precursor; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Catechin; Cell Line, Tumor; Epigenesis, Genetic; Flow Cytometry; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Neoplasms, Experimental; Rats; Xenograft Model Antitumor Assays | 2015 |
A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; STAT3 Transcription Factor; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |
Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy.
Topics: Administration, Oral; Animals; Apoptosis; Catechin; Chitosan; Drug Carriers; Gelatin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Stomach Neoplasms | 2015 |
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Survival; Chick Embryo; Drug Stability; Humans; Mice; Nanoparticles; Neoplasms, Experimental; Xenograft Model Antitumor Assays | 2009 |
Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion.
Topics: Animals; Autocrine Communication; Catechin; Cell Line, Tumor; Cell Movement; Female; Hepatocyte Growth Factor; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Paracrine Communication; Phosphorylation; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Signal Transduction | 2011 |
The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system.
Topics: Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Survival; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Female; Gold; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice; Mice, Inbred C3H; Microsomes, Liver; Neoplasms, Experimental; Particle Size; Time Factors; Xenograft Model Antitumor Assays | 2012 |
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.
Topics: Animals; Bone Marrow; Catechin; Cell Adhesion; Cells, Cultured; Chemotaxis; Endothelium; Fibroblasts; Laminin; Leukocyte Common Antigens; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasm Invasiveness; Neoplasms, Experimental; Protease Inhibitors; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; T-Lymphocyte Subsets; Urokinase-Type Plasminogen Activator | 2002 |
In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catechin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 2004 |
Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations.
Topics: Administration, Topical; Animals; Catechin; Deoxycholic Acid; Drug Evaluation, Preclinical; Drug Stability; Injections, Intralesional; Liposomes; Mice; Mice, Nude; Neoplasms, Experimental; Organophosphates; Skin; Skin Neoplasms; Tea | 2005 |
Design, semisynthesis, and evaluation of O-acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agents.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acylation; Animals; Antineoplastic Agents, Phytogenic; Catechin; Mice; Neoplasms, Experimental; Tea; Tetradecanoylphorbol Acetate | 2007 |
Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
Topics: Animals; Anticarcinogenic Agents; Catechin; Dogs; Drug Approval; Female; Flavonoids; Humans; Male; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plant Extracts; Polymers; Rats; Research Design; Tea | 1996 |